These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2948956)

  • 1. Ca2+-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate.
    Hamazaki H
    J Biol Chem; 1987 Feb; 262(4):1456-60. PubMed ID: 2948956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-mediated hemagglutination by serum amyloid P component and the inhibition by specific glycosaminoglycans.
    Hamazaki H
    Biochem Biophys Res Commun; 1988 Jan; 150(1):212-8. PubMed ID: 3276308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: enhanced binding at slightly acid pH.
    Danielsen B; Sørensen IJ; Nybo M; Nielsen EH; Kaplan B; Svehag SE
    Biochim Biophys Acta; 1997 Apr; 1339(1):73-8. PubMed ID: 9165101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of fibronectin interactions with glycosaminoglycans and identification of active proteolytic fragments.
    Yamada KM; Kennedy DW; Kimata K; Pratt RM
    J Biol Chem; 1980 Jul; 255(13):6055-63. PubMed ID: 6771264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of hepatic glycosaminoglycans in the early stages of galactosamine hepatitis: a rapid decline of heparan sulfate is followed by elevation of chondroitin sulfate and dermatan sulfate.
    Gressner AM; Köster-Eiserfunke W
    J Clin Chem Clin Biochem; 1981 Jun; 19(6):363-70. PubMed ID: 6456325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyggve-Melchior-Clausen syndrome: normal degradation of proteodermatan sulfate, proteokeratan sulfate and heparan sulfate.
    Beck M; Lücke R; Kresse H
    Clin Chim Acta; 1984 Aug; 141(1):7-15. PubMed ID: 6235983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin and heparan sulfate binding sites on B-16 melanoma cells.
    Biswas C
    J Cell Physiol; 1988 Jul; 136(1):147-53. PubMed ID: 2840440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of sulfated glycosaminoglycans in cultured endothelial cells and smooth muscle cells from bovine aorta.
    Gamse G; Fromme HG; Kresse H
    Biochim Biophys Acta; 1978 Dec; 544(3):514-28. PubMed ID: 728470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heterogeneity of dermatan sulfate and heparan sulfate in rat liver and a shift in the glycosaminoglycan contents in carbon tetrachloride-damaged liver.
    Suzuki S; Suzuki S; Nakamura N; Koizumi T
    Biochim Biophys Acta; 1976 Mar; 428(1):166-181. PubMed ID: 130930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN; Abildgaard U; Höök M
    Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction between dermatan sulphate chains. I. Affinity chromatography of copolymeric galactosaminioglycans on dermatan sulphate-substituted agarose.
    Fransson LA
    Biochim Biophys Acta; 1976 Jun; 437(1):106-15. PubMed ID: 949499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
    Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
    Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One dimensional thin-layer cellulose chromatographic separation of dermatan-, heparan-, chondroitin- and keratan sulfate.
    Wang TR
    Taiwan Yi Xue Hui Za Zhi; 1984 Aug; 83(8):737-42. PubMed ID: 6240525
    [No Abstract]   [Full Text] [Related]  

  • 15. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
    Klein DJ; Brown DM; Oegema TR
    Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionation and isolation of heparan sulfates using poly-L-lysine-Sepharose.
    Suzuki S; Koide A
    Anal Biochem; 1984 Feb; 137(1):101-5. PubMed ID: 6233913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of heparan sulfate and dermatan sulfate.
    Conrad HE
    Ann N Y Acad Sci; 1989; 556():18-28. PubMed ID: 2525357
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulfated glycosaminoglycans of cells grown in culture: dermatan sulfate disappearance in successive fibroblast subcultures.
    Mourão PA; Machado-Santelli GM
    Cell Differ; 1978 Dec; 7(6):367-74. PubMed ID: 737741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophoresis separation of glycosaminoglycans on nitrocellulose membranes.
    Volpi N
    Anal Biochem; 1996 Aug; 240(1):114-8. PubMed ID: 8811886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.